BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7202495)

  • 1. Inhibition by local anesthetics, phentolamine and propranolol of [3H]quinuclydinyl benzylate binding to central muscarinic receptors.
    Aguilar JS; Criado M; De Robertis E
    Eur J Pharmacol; 1980 Dec; 68(3):317-26. PubMed ID: 7202495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
    Aguilar JS; Salas PJ; De Robertis E
    Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle.
    Yang CM; Farley JM; Dwyer TM
    J Auton Pharmacol; 1986 Mar; 6(1):15-24. PubMed ID: 3957950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated parietal cells: [3H]QNB binding to putative cholinergic receptors.
    Ecknauer R; Thompson WJ; Johnson LR; Rosenfeld GC
    Am J Physiol; 1980 Sep; 239(3):G204-9. PubMed ID: 7435574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by atropine of the inhibition caused by Triton X-100 on central muscarinic receptors.
    Aguilar JS; Criado M; De Robertis E
    Eur J Pharmacol; 1980 May; 63(4):251-7. PubMed ID: 7389810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
    Taniguchi T; Tsukahara T; Fujiwara M
    Life Sci; 1983 Apr; 32(15):1757-63. PubMed ID: 6835022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinuclidinyl benzilate binding in house fly heads and rat brain.
    Jones SW; Sumikawa K
    J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of amine local anaesthetics with muscarinic receptors.
    Taylor WJ; Wolf A; Young JM
    Br J Pharmacol; 1980; 71(1):327-35. PubMed ID: 7470744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to analysis of radiolabeled ligand interactions with specific receptors.
    Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
    Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
    Adem A; Sabbagh M; Nordberg A
    J Neural Transm; 1988; 72(1):11-8. PubMed ID: 3379385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
    Das S; Matwyshyn GA; Bhargava HN
    Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phencyclidine on [3H]QNB binding.
    Boggan WO; Evans MG; Wallis CJ
    Life Sci; 1982 Apr; 30(14):1193-1200. PubMed ID: 7087659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local anesthetic inhibition of m1 muscarinic acetylcholine signaling.
    Hollmann MW; Fischer LG; Byford AM; Durieux ME
    Anesthesiology; 2000 Aug; 93(2):497-509. PubMed ID: 10910501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two polypeptides from Dendroaspis angusticeps venom selectively inhibit the binding of central muscarinic cholinergic receptor ligands.
    Jerusalinsky D; Cerveñasky C; Peña C; Raskovsky S; Dajas F
    Neurochem Int; 1992 Feb; 20(2):237-46. PubMed ID: 1304863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective L-[3H]quinuclidinyl benzilate-binding sites in nervous tissue of Aplysia californica: evidence for muscarinic receptors.
    Murray TF; Mpitsos GJ; Siebenaller JF; Barker DL
    J Neurosci; 1985 Dec; 5(12):3184-8. PubMed ID: 4078624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 3H-quinuclidinyl benzylate binding to cardiac muscarinic receptor by long chain fatty acids can be attenuated by ligand occupation of the receptor.
    Rauch B; Colvin RA; Messineo FC
    J Mol Cell Cardiol; 1989 May; 21(5):495-506. PubMed ID: 2778805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.